TY  - GEN
AU  - Shannon,Kevin M
TI  - Resistance in the land of molecular cancer therapeutics
SN  - 1535-6108
PY  - 2003///0515
KW  - Antineoplastic Agents
KW  - administration & dosage
KW  - Benzamides
KW  - Disease Progression
KW  - Drug Resistance, Neoplasm
KW  - genetics
KW  - Fusion Proteins, bcr-abl
KW  - chemistry
KW  - Humans
KW  - Imatinib Mesylate
KW  - Leukemia, Myelogenous, Chronic, BCR-ABL Positive
KW  - drug therapy
KW  - Mutation
KW  - Piperazines
KW  - Pyrimidines
N1  - Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.; Review
UR  - https://doi.org/10.1016/s1535-6108(02)00101-0
ER  -